---
layout: default
title: Teriparatide
description: "Teriparatide çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 166
evidence_level: L3
indication_count: 10
---

# Teriparatide

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Teriparatide è—¥å¸«ç­†è¨˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Teriparatide å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Teriparatideï¼ˆéª¨ç©©/è‰¾æ­éª¨å¾—ï¼‰æ˜¯å‰¯ç”²ç‹€è…ºç´ é¡ä¼¼ç‰©ï¼ŒTxGNN é æ¸¬å…¶å°å¦Šå¨ ç›¸é—œéª¨è³ªç–é¬†ç—‡ï¼ˆPLOï¼‰å…·ç™‚æ•ˆï¼Œå·²æœ‰è‡¨åºŠè©¦é©—åŠè±å¯Œæ–‡ç»æ”¯æŒã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Teriparatide |
| DrugBank ID | DB06285 |
| å°ç£å•†å“å | éª¨ç©©æ³¨å°„æ¶²ã€è‰¾æ­éª¨å¾—æ³¨å°„æ¶²ã€ç¦ç©©éª¨æ³¨å°„æ¶²ç­‰ |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | åœç¶“å¾Œéª¨è³ªç–é¬†ç—‡ã€ç³–çš®è³ªæ¿€ç´ èª˜ç™¼éª¨è³ªç–é¬†ç—‡ã€ç”·æ€§éª¨è³ªç–é¬†ç—‡ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | duodenal ulcer (disease)ã€non-syndromic esophageal malformationã€postmenopausal osteoporosisã€duodenal obstructionã€duodenogastric refluxã€esophageal diseaseã€Worth syndromeã€autosomal dominant neovascular inflammatory vitreoretinopathyã€pregnancy associated osteoporosisã€succinyl-CoA:3-ketoacid CoA transferase deficiency |
| æœ€é«˜è­‰æ“šç­‰ç´š | **L2**ï¼ˆå–®ä¸€ RCT / å¤šå€‹ Phase 2ï¼‰ |
| TxGNN åˆ†æ•¸ | 0.834ï¼ˆå¦Šå¨ ç›¸é—œéª¨è³ªç–é¬†ç—‡ï¼‰ |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. duodenal ulcer (disease)</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.86%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>### ä½œç”¨æ©Ÿè½‰æ”¯æŒ</p>

<p>Teriparatide æ˜¯äººé¡å‰¯ç”²ç‹€è…ºç´ ï¼ˆPTHï¼‰çš„æ´»æ€§ç‰‡æ®µï¼ˆ1-34 æ°¨åŸºé…¸ï¼‰ï¼Œé€éé–“æ­‡æ€§çµ¦è—¥åˆºæ¿€æˆéª¨ç´°èƒæ´»æ€§ï¼Œä¿ƒé€²éª¨å½¢æˆã€‚æ­¤æ©Ÿè½‰å°æ‰€æœ‰ç—…å› å°è‡´çš„éª¨è³ªç–é¬†ç—‡ç†è«–ä¸Šå‡æœ‰æ•ˆã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. non-syndromic esophageal malformation</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.85%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. duodenal obstruction</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.78%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. duodenogastric reflux</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.78%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. esophageal disease</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.74%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ3 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25118550/" target="_blank">25118550</a></td><td>2014</td><td>Article</td><td>South African medical journal </td><td>The safety of osteoporosis medication.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19412101/" target="_blank">19412101</a></td><td>2009</td><td>Article</td><td>Current opinion in rheumatolog</td><td>Osteoporosis treatments and adverse events.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26992073/" target="_blank">26992073</a></td><td>2016</td><td>Article</td><td>The British journal of dermato</td><td>Worsening of calcinosis cutis with teriparatide treatment in two osteoporotic pa...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. Worth syndrome</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.69%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. autosomal dominant neovascular inflammatory vitreoretinopathy</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.66%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. pregnancy associated osteoporosis</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.55%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ2 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00277706" target="_blank">NCT00277706</a></td><td>PHASE1</td><td>COMPLETED</td><td>40</td><td>Impact of Parathyroid Hormone (1-34) on Osseous Regeneration in the Oral Cavity</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02440581" target="_blank">NCT02440581</a></td><td>NA</td><td>COMPLETED</td><td>141</td><td>Renal Osteodystrophy: A Fresh Approach</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39008200/" target="_blank">39008200</a></td><td>2024</td><td>Article</td><td>Endocrine</td><td>Effective strategies for pregnancy and lactation-associated osteoporosis: teripa...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37708365/" target="_blank">37708365</a></td><td>2024</td><td>Article</td><td>The Journal of clinical endocr</td><td>Comparative Effectiveness of Therapeutic Interventions in Pregnancy and Lactatio...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33620518/" target="_blank">33620518</a></td><td>2022</td><td>Article</td><td>Calcified tissue international</td><td>&quot;Pregnancy and Lactation Associated Osteoporosis&quot;.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34132853/" target="_blank">34132853</a></td><td>2021</td><td>Article</td><td>Calcified tissue international</td><td>Teriparatide Treatment in Patients with Pregnancy- and Lactation-Associated Oste...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37175006/" target="_blank">37175006</a></td><td>2023</td><td>Article</td><td>Diagnostics (Basel, Switzerlan</td><td>Bridging the Gap: Pregnancy-And Lactation-Associated Osteoporosis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37551335/" target="_blank">37551335</a></td><td>2023</td><td>Article</td><td>International journal of women</td><td>Recent Insights into Pregnancy and Lactation-Associated Osteoporosis (PLO).</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28084543/" target="_blank">28084543</a></td><td>2017</td><td>Article</td><td>Zeitschrift fur Rheumatologie</td><td>[Pregnancy and lactation-associated osteoporosis].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34036859/" target="_blank">34036859</a></td><td>2022</td><td>Article</td><td>Climacteric : the journal of t</td><td>Premenopausal osteoporosis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39624554/" target="_blank">39624554</a></td><td>2024</td><td>Article</td><td>Cureus</td><td>Pregnancy- and Lactation-Associated Osteoporosis: A Literature Review Based on a...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34037833/" target="_blank">34037833</a></td><td>2021</td><td>Article</td><td>Calcified tissue international</td><td>Bone Density After Teriparatide Discontinuation With or Without Antiresorptive T...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35903718/" target="_blank">35903718</a></td><td>2022</td><td>Article</td><td>Geburtshilfe und Frauenheilkun</td><td>Effect of Teriparatide on Subsequent Fracture and Bone Mineral Density in 47 Wom...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36676643/" target="_blank">36676643</a></td><td>2022</td><td>Article</td><td>Medicina (Kaunas, Lithuania)</td><td>Pregnancy and Lactation-Associated Osteoporosis Successfully Treated with Romoso...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39976715/" target="_blank">39976715</a></td><td>2025</td><td>Article</td><td>Zeitschrift fur Rheumatologie</td><td>[Pregnancy and lactation-associated osteoporosis: risk factors and treatment].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40205203/" target="_blank">40205203</a></td><td>2025</td><td>Article</td><td>Osteoporosis international : a</td><td>Clinical presentation, risk factors and management of pregnancy-associated osteo...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37819437/" target="_blank">37819437</a></td><td>2023</td><td>Article</td><td>Calcified tissue international</td><td>Clinical Features, Incidence and Treatment Outcome in Pregnancy-Associated Osteo...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30590363/" target="_blank">30590363</a></td><td>2019</td><td>Article</td><td>Clinical calcium</td><td>[Pharmacological treatment for pregnancy and lactation associated osteoporosis.]...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36764958/" target="_blank">36764958</a></td><td>2023</td><td>Article</td><td>Calcified tissue international</td><td>Bone Microarchitecture and Strength Changes During Teriparatide and Zoledronic A...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/40837111/" target="_blank">40837111</a></td><td>2025</td><td>Article</td><td>Journal of the Endocrine Socie</td><td>Pregnancy and Lactation Associated Bone Fragility.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/41076574/" target="_blank">41076574</a></td><td>2025</td><td>Article</td><td>Current opinion in endocrinolo</td><td>Approach to premenopausal osteoporosis.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28394826/" target="_blank">28394826</a></td><td>2017</td><td>Article</td><td>Current opinion in rheumatolog</td><td>Osteoporosis in premenopausal women.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. succinyl-CoA:3-ketoacid CoA transferase deficiency</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.47%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. amenorrhea (disease)</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.04%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ1 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36303862/" target="_blank">36303862</a></td><td>2022</td><td>Article</td><td>Frontiers in endocrinology</td><td>Bone health in functional hypothalamic amenorrhea: What the endocrinologist need...</td></tr>
</tbody>
</table>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

### å·²æ ¸å‡†ç”¢å“ï¼ˆå…± 12 é …ï¼‰

| è¨±å¯è­‰è™Ÿ | å•†å“å | å» å•† | è¦æ ¼ |
|----------|--------|------|------|
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬026543è™Ÿ | éª¨ç©©æ³¨å°„æ¶² | ç¦®ä¾† | 20mcg/80mcL |
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬027865è™Ÿ | è‰¾æ­éª¨å¾—æ³¨å°„æ¶² | å°ç£æ±æ´‹ | 20mcg/80mcL |
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬028123è™Ÿ | ç¦ç©©éª¨æ³¨å°„æ¶² | ä¸­åŒ– | 20mcg/80mcL |
| è¡›éƒ¨è—¥è¼¸å­—ç¬¬028456è™Ÿ | å¯ç«‹éª¨æ³¨å°„æ¶² | å¥å–¬ | 20mcg/80mcL |

### å¥ä¿çµ¦ä»˜ç‹€æ…‹

**çµ¦ä»˜æ¢ä»¶**ï¼ˆéœ€äº‹å‰å¯©æŸ¥ï¼‰ï¼š
1. åœç¶“å¾Œå©¦å¥³éª¨è³ªç–é¬†ç—‡ä¸”æ›¾æœ‰è„Šæ¤æˆ–é«–éƒ¨éª¨æŠ˜
2. ç³–çš®è³ªæ¿€ç´ èª˜ç™¼éª¨è³ªç–é¬†ç—‡
3. éª¨å¯†åº¦ T-score â‰¤ -3.0 ä¸”æœ‰éª¨æŠ˜å²
4. æœ€é•·çµ¦ä»˜ 24 å€‹æœˆ

**PLO çµ¦ä»˜ç¾æ³**ï¼šç›®å‰ PLO éæ˜ç¢ºçµ¦ä»˜é©æ‡‰ç—‡ï¼Œéœ€å€‹æ¡ˆç”³è«‹ã€‚

## å®‰å…¨æ€§è€ƒé‡

### è—¥ç‰©äº¤äº’ä½œç”¨

| äº¤äº’ä½œç”¨è—¥ç‰© | åš´é‡ç¨‹åº¦ | èªªæ˜ |
|--------------|----------|------|
| Calcitriol | è¼•åº¦ | å¯èƒ½å¢åŠ é«˜è¡€ï¿½iteé¢¨éšª |
| Digoxin | ä¸­åº¦ | é«˜è¡€éˆ£å¯èƒ½å¢å¼·æ¯›åœ°é»ƒæ¯’æ€§ |
| Furosemide | è¼•åº¦ | å¯èƒ½å½±éŸ¿éˆ£è³ªå¹³è¡¡ |
| Thiazide åˆ©å°¿åŠ‘ | è¼•åº¦ | å¯èƒ½å¢åŠ é«˜è¡€éˆ£é¢¨éšª |

### ä¸»è¦ä¸è‰¯åæ‡‰

- **å¸¸è¦‹**ï¼šå™å¿ƒã€é ­æšˆã€è…¿éƒ¨æŠ½ç­‹ã€é—œç¯€ç—›
- **è¼ƒå°‘è¦‹**ï¼šé«˜è¡€éˆ£ã€é«˜å°¿éˆ£
- **ç½•è¦‹**ï¼šéª¨è‚‰ç˜¤ï¼ˆé»‘æ¡†è­¦å‘Šï¼ŒåŸºæ–¼å‹•ç‰©å¯¦é©—ï¼‰

### ç‰¹æ®Šæ—ç¾¤æ³¨æ„äº‹é …

- **å“ºä¹³æœŸ**ï¼šå»ºè­°åœæ­¢å“ºä¹³å¾Œä½¿ç”¨ï¼ˆPLO æ‚£è€…è€ƒé‡ï¼‰
- **éª¨è‚‰ç˜¤é¢¨éšª**ï¼š
  - æœ‰éª¨ Paget æ°ç—…å²è€…ç¦ç”¨
  - æ›¾æ¥å—éª¨éª¼æ”¾å°„æ²»ç™‚è€…ç¦ç”¨
  - å…’ç«¥åŠé’å°‘å¹´ç¦ç”¨
- **ç´¯ç©ä½¿ç”¨**ï¼šçµ‚ç”Ÿä½¿ç”¨ä¸è¶…é 2 å¹´

### PLO æ‚£è€…ç‰¹æ®Šè€ƒé‡

- æ‚£è€…å¤šç‚ºå¹´è¼•å¥³æ€§ï¼ˆ20-40 æ­²ï¼‰
- å¯èƒ½è¨ˆç•«å†æ¬¡æ‡·å­•
- éœ€è©•ä¼°éª¨è‚‰ç˜¤é•·æœŸé¢¨éšªï¼ˆé›–ç„¶æ¥µä½ï¼‰
- å»ºè­°åœ¨åœæ­¢å“ºä¹³å¾Œé–‹å§‹æ²»ç™‚

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

**ä¹³è£½å“ï¼ˆç‰›å¥¶ã€å„ªæ ¼ã€èµ·å¸ï¼‰** ğŸŸ¢ Minor
- å½±éŸ¿ï¼šç¢ºä¿è¶³å¤ éˆ£è³ªæ”å–ä»¥æ”¯æŒéª¨è³ªç”Ÿæˆ
- å»ºè­°ï¼šå»ºè­°æ”å–è¶³å¤ éˆ£è³ªå’Œç¶­ç”Ÿç´  D


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Hypotension, Orthostatic** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚é¢¨éšªåŒ…æ‹¬ï¼šä½è¡€å£“ã€‚

**è…è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

**Urolithiasis** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

**å‰¯ç”²ç‹€è…ºæ©Ÿèƒ½äº¢é€²** ğŸŸ¢ Minor
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

**Neoplasms** ğŸŸ¢ Minor
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚

**éª¨è³ªç–é¬†ç—‡** ğŸŸ¢ Minor
- ä¸å»ºè­°ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### é æ¸¬å¯ä¿¡åº¦è©•ä¼°

| é æ¸¬é©æ‡‰ç—‡ | è­‰æ“šç­‰ç´š | å¯ä¿¡åº¦ | å»ºè­° |
|------------|----------|--------|------|
| å¦Šå¨ ç›¸é—œéª¨è³ªç–é¬†ç—‡ | L2 | é«˜ | å¼·çƒˆå»ºè­°ç´å…¥é©æ‡‰ç—‡ |
| åäºŒæŒ‡è…¸æ½°ç˜ | L5 | ä½ | æ©Ÿè½‰ä¸æ˜ç¢ºï¼Œä¸å»ºè­° |
| é£Ÿé“ç–¾ç—… | L5 | ä½ | æ©Ÿè½‰ä¸æ˜ç¢ºï¼Œä¸å»ºè­° |

### è‡¨åºŠæ‡‰ç”¨å»ºè­°

1. **PLO æ²»ç™‚é¦–é¸**ï¼š
   - Teriparatide æ‡‰è€ƒæ…®ä½œç‚º PLO çš„ä¸€ç·šæ²»ç™‚é¸æ“‡
   - ç‰¹åˆ¥é©åˆæœ‰å¤šç™¼æ€§æ¤é«”éª¨æŠ˜çš„åš´é‡ PLO æ‚£è€…
   - å¯ä¿ƒé€²éª¨å½¢æˆï¼Œæ¯”æŠ—éª¨å¸æ”¶è—¥ç‰©æ›´é©åˆå¹´è¼•æ‚£è€…

2. **æ²»ç™‚æ™‚æ©Ÿ**ï¼š
   - å»ºè­°åœ¨ç¢ºè¨º PLO ä¸”åœæ­¢å“ºä¹³å¾Œé–‹å§‹
   - ç™‚ç¨‹ 18-24 å€‹æœˆ
   - ä¹‹å¾Œè½‰æ›ç‚ºæŠ—éª¨å¸æ”¶è—¥ç‰©ç¶­æŒ

3. **ç›£æ¸¬å»ºè­°**ï¼š
   - æ²»ç™‚å‰å¾Œéª¨å¯†åº¦æª¢æ¸¬
   - å®šæœŸç›£æ¸¬è¡€éˆ£
   - è¿½è¹¤éª¨æŠ˜ç™’åˆæƒ…æ³

### å¥ä¿çµ¦ä»˜å»ºè­°

å»ºè­°å‘å¥ä¿ç½²ç”³è«‹å°‡ã€Œå¦Šå¨ åŠå“ºä¹³ç›¸é—œéª¨è³ªç–é¬†ç—‡ã€ç´å…¥ Teriparatide çµ¦ä»˜é©æ‡‰ç—‡ï¼Œç†ç”±ï¼š
1. æœ‰è‡¨åºŠè©¦é©—é€²è¡Œä¸­
2. å¤§é‡æ–‡ç»æ”¯æŒç™‚æ•ˆ
3. æ‚£è€…ç‚ºå¹´è¼•å¥³æ€§ï¼Œéª¨å½¢æˆä¿ƒé€²åŠ‘è¼ƒæŠ—éª¨å¸æ”¶è—¥ç‰©æ›´é©åˆ
4. å…¶ä»–åœ‹å®¶å·²æœ‰ä½¿ç”¨ç¶“é©—

---

*æœ¬ç­†è¨˜ç”± TxGNN é æ¸¬ç³»çµ±ç”¢ç”Ÿï¼Œåƒ…ä¾›ç ”ç©¶åƒè€ƒï¼Œä¸æ§‹æˆé†«ç™‚å»ºè­°ã€‚*
*æ›´æ–°æ—¥æœŸï¼š2026-02-11*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Cephalexin]({{ "/drugs/cephalexin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Caplacizumab]({{ "/drugs/caplacizumab/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Thiamine]({{ "/drugs/thiamine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Tizanidine]({{ "/drugs/tizanidine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Tofacitinib]({{ "/drugs/tofacitinib/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Teriparatideè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/teriparatide/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_teriparatide,
  title = {Teriparatideè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/teriparatide/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
